{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T12:10:21Z","timestamp":1790511021257,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"3-4","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.ejps.2009.02.014","type":"journal-article","created":{"date-parts":[[2009,3,7]],"date-time":"2009-03-07T09:34:19Z","timestamp":1236418459000},"page":"272-278","source":"Crossref","is-referenced-by-count":45,"title":["Pharmacokinetics of a new 10% intravenous immunoglobulin in patients receiving replacement therapy for primary immunodeficiency"],"prefix":"10.1016","volume":"37","author":[{"given":"Richard L.","family":"Wasserman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Church","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans H.","family":"Peter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Sleasman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Melamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Bichler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2009.02.014_bib1","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1046\/j.1423-0410.2003.00278.x","article-title":"Pharmacokinetics of total immunoglobulin G and immunoglobulin G subclasses in patients undergoing replacement therapy for primary immunodeficiency syndromes","volume":"84","author":"Alyanakian","year":"2003","journal-title":"Vox Sang."},{"key":"10.1016\/j.ejps.2009.02.014_bib2","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/0090-1229(82)90022-8","article-title":"Use of intravenous gamma-globulin in antibody immunodeficiency: results of a multicenter controlled trial","volume":"22","author":"Ammann","year":"1982","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.ejps.2009.02.014_bib3","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1046\/j.1423-0410.2003.00286.x","article-title":"Pharmacokinetics and tolerability of a new intravenous immunoglobulin preparation, IGIV-C, 10% (Gamunex, 10%)","volume":"84","author":"Ballow","year":"2003","journal-title":"Vox Sang."},{"key":"10.1016\/j.ejps.2009.02.014_bib4","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/s10875-007-9107-x","article-title":"A multicenter, prospective, open label, historically controlled clinical trial to evaluate efficacy and safety in primary immunodeficiency diseases (PID) patients of Flebogamma 5% DIF, the next generation of Flebogamma","volume":"27","author":"Berger","year":"2007","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.ejps.2009.02.014_bib5","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1023\/B:JOCI.0000029108.18995.61","article-title":"Safety, efficacy, and pharmacokinetics of Flebogamma 5% [immune globulin intravenous (human)] for replacement therapy in primary immunodeficiency diseases","volume":"24","author":"Berger","year":"2004","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.ejps.2009.02.014_bib6","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1423-0410.2006.00764.x","article-title":"Prospective open-label study of pharmacokinetics, efficacy and safety of a new 10% liquid intravenous immunoglobulin in patients with hypo- or agammaglobulinemia","volume":"90","author":"Bjorkander","year":"2006","journal-title":"Vox Sang."},{"key":"10.1016\/j.ejps.2009.02.014_bib7","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1081-1206(10)61142-8","article-title":"Practice parameter for the diagnosis and management of primary immunodeficiency","volume":"94","author":"Bonilla","year":"2005","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.ejps.2009.02.014_bib8","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1056\/NEJM199107113250207","article-title":"The use of intravenous immune globulin in immunodeficiency diseases","volume":"325","author":"Buckley","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejps.2009.02.014_bib9","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1023\/A:1006678312925","article-title":"The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy","volume":"20","author":"Chapel","year":"2000","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.ejps.2009.02.014_bib10","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s10875-006-9025-3","article-title":"Efficacy, safety and tolerability of a new 10% liquid intravenous immune globulin [IGIV 10%] in patients with primary immunodeficiency","volume":"26","author":"Church","year":"2006","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.ejps.2009.02.014_bib11","doi-asserted-by":"crossref","first-page":"435","DOI":"10.7326\/0003-4819-101-4-435","article-title":"Efficacy of intravenous immunoglobulin in primary humoral immunodeficiency disease","volume":"101","author":"Cunningham-Rundles","year":"1984","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejps.2009.02.014_bib12","doi-asserted-by":"crossref","first-page":"165","DOI":"10.7326\/0003-4819-135-3-200108070-00008","article-title":"The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trial","volume":"135","author":"Eijkhout","year":"2001","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejps.2009.02.014_bib13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/ard.59.1.77","article-title":"Acute myocardial infarction associated with high dose intravenous immunoglobulin infusion for autoimmune disorders. A study of four cases","volume":"59","author":"Elkayam","year":"2000","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ejps.2009.02.014_bib14","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/01.mph.0000163214.37147.5a","article-title":"Antibody titers and immune response to diphtheria-tetanus-pertussis and measles-mumps-rubella vaccination in children treated for acute lymphoblastic leukemia","volume":"27","author":"Ercan","year":"2005","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.ejps.2009.02.014_bib15","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jaci.2007.08.053","article-title":"Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee","volume":"120","author":"Geha","year":"2007","journal-title":"J. Allergy. Clin. Immunol."},{"key":"10.1016\/j.ejps.2009.02.014_bib16","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.clim.2007.04.011","article-title":"Active vaccination in patients with common variable immunodeficiency (CVID)","volume":"124","author":"Goldacker","year":"2007","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.ejps.2009.02.014_bib17","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.1073\/pnas.93.11.5512","article-title":"The protection receptor for IgG catabolism is the beta2-microglobulin-containing neonatal intestinal transport receptor","volume":"93","author":"Junghans","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejps.2009.02.014_bib18","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.jaci.2006.09.036","article-title":"Validation of current joint American Academy of Allergy, Asthma & Immunology and American College of Allergy, Asthma and Immunology guidelines for antibody response to the 23-valent pneumococcal vaccine using a population of HIV-infected children","volume":"118","author":"Kamchaisatian","year":"2006","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejps.2009.02.014_bib19","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1592\/phco.26.6.813","article-title":"Pharmacokinetics of intravenous immunoglobulin: a systematic review","volume":"26","author":"Koleba","year":"2006","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ejps.2009.02.014_bib20","doi-asserted-by":"crossref","first-page":"E62","DOI":"10.1542\/peds.108.4.e62","article-title":"Preimmunization anti-pneumococcal antibody levels are protective in a majority of patients with cystic fibrosis","volume":"108","author":"Lahiri","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.ejps.2009.02.014_bib21","first-page":"634","article-title":"The half-lives of IgG subclasses and specific antibodies in patients with primary immunodeficiency who are receiving intravenously administered immunoglobulin","volume":"112","author":"Mankarious","year":"1988","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.ejps.2009.02.014_bib22","series-title":"Intravenous Immunoglobulins in Clinical Practice","article-title":"Pharmacokinetics of intravenous immunoglobulin preparations","author":"Morell","year":"1997"},{"key":"10.1016\/j.ejps.2009.02.014_bib23","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1172\/JCI106279","article-title":"Metabolic properties of IgG subclasses in man","volume":"49","author":"Morell","year":"1970","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejps.2009.02.014_bib24","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0092-1157(88)90003-0","article-title":"IgG subclass distribution among antibodies to varicella-zoster virus in human varicella\/zoster immunoglobulin preparations and the corresponding donor plasma","volume":"16","author":"Moyner","year":"1988","journal-title":"J. Biol. Stand."},{"key":"10.1016\/j.ejps.2009.02.014_bib25","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/0002-9343(84)90324-3","article-title":"Comparison of high-dose and low-dose intravenous immunoglobulin therapy in patients with primary immunodeficiency diseases","volume":"76","author":"Ochs","year":"1984","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejps.2009.02.014_bib26","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1023\/B:JOCI.0000025453.23817.3f","article-title":"Octagam 5%, an intravenous IgG product, is efficacious and well tolerated in subjects with primary immunodeficiency diseases","volume":"24","author":"Ochs","year":"2004","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.ejps.2009.02.014_bib27","doi-asserted-by":"crossref","first-page":"S525","DOI":"10.1016\/j.jaci.2006.01.015","article-title":"Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology","volume":"117","author":"Orange","year":"2006","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejps.2009.02.014_bib28","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1056\/NEJM199508173330707","article-title":"The primary immunodeficiencies","volume":"333","author":"Rosen","year":"1995","journal-title":"N. Engl. J. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.ejps.2009.02.014_bib29","first-page":"15","article-title":"Individualizing the dose of intravenous immune serum globulin for therapy of patients with primary humoral immunodeficiency","volume":"49","author":"Schiff","year":"1958","journal-title":"Vox Sang."},{"key":"10.1016\/j.ejps.2009.02.014_bib30","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/BF00918706","article-title":"Alterations in the half-life and clearance of IgG during therapy with intravenous gamma-globulin in 16 patients with severe primary humoral immunodeficiency","volume":"6","author":"Schiff","year":"1986","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.ejps.2009.02.014_bib31","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.4049\/jimmunol.140.9.3200","article-title":"Human antibodies to group A streptococcal carbohydrate. Ontogeny, subclass restriction, and clonal diversity","volume":"140","author":"Shackelford","year":"1988","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejps.2009.02.014_bib32","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1159\/000227231","article-title":"Effect of various doses of intravenous polyclonal IgG on in vivo levels of 12 pneumococcal antibodies in patients with chronic lymphocytic leukaemia and multiple myeloma","volume":"50","author":"Sklenar","year":"1993","journal-title":"Oncology"},{"key":"10.1016\/j.ejps.2009.02.014_bib33","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/00006454-199707000-00012","article-title":"Human intravenous immunoglobulin in primary and secondary antibody deficiencies","volume":"16","author":"Stiehm","year":"1997","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.ejps.2009.02.014_bib34","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1128\/JCM.20.1.94-98.1984","article-title":"Virus-specific immunoglobulin G subclasses in herpes simplex and varicella-zoster virus infections","volume":"20","author":"Sundqvist","year":"1984","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ejps.2009.02.014_bib35","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF00192385","article-title":"Pharmacokinetic characteristics and tolerability of a novel intravenous immunoglobulin preparation","volume":"49","author":"Thurmann","year":"1995","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2009.02.014_bib36","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1128\/JCM.25.4.748-750.1987","article-title":"Differential immunoglobulin G subclass antibody titers to respiratory syncytial virus F and G glycoproteins in adults","volume":"25","author":"Wagner","year":"1987","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ejps.2009.02.014_bib37","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1182\/blood.V99.5.1544","article-title":"Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease","volume":"99","author":"Warnatz","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ejps.2009.02.014_bib38","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1182\/blood-2007-06-091744","article-title":"The EUROclass trial: defining subgroups in common variable immunodeficiency","volume":"111","author":"Wehr","year":"2008","journal-title":"Blood"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098709000694?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098709000694?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T08:31:07Z","timestamp":1684917067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098709000694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":38,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0928098709000694"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2009.02.014","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}